NeoGenomics, Inc. Share Price
NASDAQ: NEO | Mid CapNeoGenomics, Inc. Stock Performance
NeoGenomics, Inc. Share Price Today
As of 31 October 2026, NeoGenomics, Inc.'s share price is $17.37. The stock opened at $17.84, compared to its previous close of $17.92. During today's trading session, NeoGenomics, Inc.'s share price traded between $17.09 and $18.11, with an average price of $17.60. Over the past 52 weeks, the stock has recorded a high of $20.02 and a low of $7.07. In terms of performance, NeoGenomics, Inc.'s share price has risen by 87.48% over the last six months and is up 77.79% on a year-on-year basis.
NeoGenomics, Inc. Share Price Chart
NeoGenomics, Inc. Quarterly Profit & Loss
All figures in USD
NeoGenomics, Inc. Annual Profit & Loss
All figures in USD
About NeoGenomics, Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
NeoGenomics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $18.11 | $17.36 | -5.50% |
Sep 2026 | $17.76 | $18.37 | -1.47% |
Aug 2026 | $15.60 | $18.64 | +21.98% |
Jul 2026 | $14.60 | $15.29 | +4.80% |
Jun 2026 | $10.60 | $14.59 | +38.64% |
May 2026 | $9.41 | $10.52 | +13.55% |
Apr 2026 | $7.53 | $9.27 | +25.03% |
Mar 2026 | $9.72 | $7.41 | -24.54% |
Feb 2026 | $12.10 | $9.82 | -18.64% |
Jan 2026 | $11.79 | $12.07 | +2.72% |
Dec 2025 | $11.92 | $11.75 | -2.97% |
Nov 2025 | $9.84 | $12.11 | +23.95% |